Inventor · disambiguated record
Ryszard Kole
Also filed as: KOLE RYSZARD · KOLE RYSZARD M
29 granted patents·23 pending applications·1,467 citations·filing 1995–2024
98Inventor score
Files withSAREPTA THERAPEUTICS INC27ROCHE INNOVATION CT COPENHAGEN AS4SAZANI PETER L4UNIV NORTH CAROLINA4AVI BIOPHARMA INC3
Top patents by PatentIndex Score
52 records- 0199US8835402B2Compound and method for treating myotonic dystrophySAREPTA THERAPEUTICS INC·Filed 2013·Granted Sep 16, 2014·91 cites·10 claims
- 0298US9447417B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·61 cites·4 claims
- 0398US9447416B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·40 cites·8 claims
- 0498US9434948B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 6, 2016·52 cites·8 claims
- 0598US9234198B1Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Jan 12, 2016·35 cites·8 claims
- 0698US8865883B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2013·Granted Oct 21, 2014·95 cites·21 claims
- 0798US8501703B2Chimeric oligomeric compounds for modulation of splicingBENNETT C FRANK·Filed 2006·Granted Aug 6, 2013·99 cites·24 claims
- 0897US9453225B2Multiple exon skipping compositions for DMDSAREPTA THERAPEUTICS INC·Filed 2015·Granted Sep 27, 2016·23 cites·4 claims
- 0996US9157081B2Chimeric oligomeric compounds for modulation of splicingISIS PHARMACEUTICALS INC·Filed 2013·Granted Oct 13, 2015·29 cites·6 claims
- 1096US8871918B2Multiple exon skipping compositions for DMDSAZANI PETER·Filed 2009·Granted Oct 28, 2014·69 cites·38 claims
- 1195US5976879AAntisense oligonucleotides which combat aberrant splicing and methods of using the sameUNIV NORTH CAROLINA·Filed 1999·Granted Nov 2, 1999·211 cites·13 claims
- 1295US5916808AAntisense oligonucleotides which combat aberrant splicing and methods of using the sameUNIV NORTH CAROLINA·Filed 1997·Granted Jun 29, 1999·198 cites·13 claims
- 1395US5627274AAntisense oligonucleotides which combat aberrant splicing and methods of using the sameUNIV NORTH CAROLINA·Filed 1995·Granted May 6, 1997·179 cites·4 claims
- 1494US8741863B2Compound and method for treating myotonic dystrophyMOULTON HONG M·Filed 2011·Granted Jun 3, 2014·60 cites·15 claims
- 1594US7884194B2Soluble HER2 and HER3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of diseaseAVI BIOPHARMA INC·Filed 2008·Granted Feb 8, 2011·13 cites·4 claims
- 1694US5665593AAntisense oligonucleotides which combat aberrant splicing and methods of using the sameUNIV NORTH CAROLINA·Filed 1995·Granted Sep 9, 1997·168 cites·13 claims
- 1793US2025154507A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1892US11071749B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2019·Granted Jul 27, 2021·3 cites·12 claims
- 1992US9833468B2Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2016·Granted Dec 5, 2017·12 cites·51 claims
- 2091US9326992B2Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2012·Granted May 3, 2016·16 cites·86 claims
- 2185US10927378B2Compound and method for treating myotonic dystrophySAREPTA THERAPEUTICS INC·Filed 2018·Granted Feb 23, 2021·1 cites·32 claims
- 2285US9066967B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2012·Granted Jun 30, 2015·4 cites·86 claims
- 2384US10822608B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2017·Granted Nov 3, 2020·2 cites·4 claims
- 2484US10076536B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2017·Granted Sep 18, 2018·2 cites·17 claims
- 2582US10106796B2Compound and method for treating myotonic dystrophySAREPTA THERAPEUTICS INC·Filed 2014·Granted Oct 23, 2018·3 cites·16 claims
- 2676US2021180060A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2776US2020283776A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 2875US9682097B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2015·Granted Jun 20, 2017·1 cites·49 claims
- 2975US2022002733A1Compound and method for treating myotonic dystrophySAREPTA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3072US2019127738A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3171US2019284556A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3269US2015152415A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3368US2018066259A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3467US11802283B2Oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2020·Granted Oct 31, 2023·0 cites·4 claims
- 3566US11236329B2Compound and method for treating myotonic dystrophySAREPTA THERAPEUTICS INC·Filed 2014·Granted Feb 1, 2022·0 cites·11 claims
- 3666US2017292125A1Multiple exon skipping compositions for dmdSAREPTA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3766US2019017052A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 3864US10398721B2Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNASAREPTA THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·0 cites·19 claims
- 3964US2010016215A1Compound and method for treating myotonic dystrophyAVI BIOPHARMA INC·Filed 2009·Application pending·0 cites
- 4064US2018051290A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
- 4162US2014057968A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseSAZANI PETER L·Filed 2013·Application pending·0 cites
- 4262US2017191067A1Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of DiseaseROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
- 4362US2007105807A1Splice switch oligomers for TNF superfamily receptors and their use in treatment of diseaseSAZANI PETER L·Filed 2006·Application pending·0 cites
- 4457US2011269665A1Compound and method for treating myotonic dystrophyAVI BIOPHARMA INC·Filed 2011·Application pending·0 cites
- 4556US2011237521A1Splice switching oligomers for tnf superfamily receptors and their use in treatment of diseaseSAZANI PETER L·Filed 2010·Application pending·0 cites
- 4655US7785834B2Soluble TNF receptors and their use in treatment of diseaseERCOLE BIOTECH INC·Filed 2007·Granted Aug 31, 2010·0 cites·6 claims
- 4755US2015167004A1Oligonucleotide inhibitors of dna methyltransferases and their use in treating diseasesMETHEOR THERAPEUTICS CORP·Filed 2013·Application pending·0 cites
- 4845US2003114411A1Stable alteration on pre-mRNA splicing patterns by modified RNAsFiled 2002·Application pending·0 cites
- 4945US2004137472A1Methods and compositions for modification of splicing of pre-mRNAKOLE RYSZARD·Filed 2003·Application pending·0 cites
- 5040US2012142759A1Soluble thf receptors and their use in treatment of diseaseSAZANI PETER L·Filed 2007·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ryszard Kole files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →